University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 11 of 23
Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses
NCT02852057
Energy Drinks and Vascular Function
NCT03324256
Race-Specific Propofol Titration to Effect for Procedural Sedation
NCT03290859
Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation
NCT03359902
Absorption of Transdermal Vitamins in Post Bariatric Surgery Patients
NCT03360435
UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT Survivors
NCT03377010
Airway Protective Mechanisms in PD (R01)
NCT03321019
Efficacy of Pea Hull Fiber in Chronic Disease
NCT03354364
30-to-90 Day Challenge: Effects of Alcohol Cessation on Health Outcomes
NCT03353701
B. Lactis B94 Effects of Gastrointestinal Function
NCT03277157
ANCHORS Study: UH2 Project
NCT03360422
Study to Evaluate the Efficacy of Removing Skin Tags With Digiclamp
NCT03259295
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
NCT03247738
TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)
NCT02921737
An Interactive Patient-Centered Consent for Research Using Medical Records
NCT03063268
Diet and Exercise in Pompe Disease
NCT02363153
Exercise Training in Dystonia
NCT03318120
Music in Urgent and Emergent Settings
NCT03327077
Comparison of Primary Extubation Failure Between NIPPV and NI-NAVA
NCT03242057
Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease
NCT02240407
Can A Nutrition Education Immersion Program Foster Sustainable Improvements in Clinical Parameters Over Time?
NCT03320551
Alcohol Use and Mental Health - Pilot Test of Video-assisted Drinking Topography
NCT03314454
Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity
NCT03096288
Exposure Therapy for Auditory Sensitivity in Autism
NCT03206996
Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)
NCT02920450
Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage
NCT02934321
Effects of Acute Intermittent Hypoxia on Sensory Function in Healthy Adults
NCT03283072
Fibrinolytic Therapy Versus Medical Thoracoscopy
NCT03213834
Exercise Intervention for Unilateral Amputees With Low Back Pain
NCT03300375
The BEACH Interview Study- Pregnant and Breastfeeding Mothers
NCT03036696
Probiotics on Stress-associated Gastrointestinal Function in University Students
NCT03056846
Next Science Antimicrobial Mouth Rinse Study
NCT03154021
Primary Prevention Youth Suicide Trial in Colorado High Schools Prevention Among Colorado High School Students
NCT03014271
Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101)
NCT03016130
Sex Differences, Cognitive Training & Emotion Processing
NCT03137654
Curcumin and Function in Older Adults
NCT03085680
ThErapy Adherence Management in Veterans
NCT03243487
Augmenting Cognitive Training In Older Adults
NCT02851511
Abdominal Wall Block Study
NCT03074240
Health Benefits of Gardening
NCT03266120
Intranasal Oxytocin for Infants With Prader-Willi Syndrome
NCT03245762
Palliative Care for Elderly Outpatients
NCT03209440
Type 1 Diabetes Data Acquisition and Transfer Adherence Study
NCT03228004
TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003)
NCT02920476
Intermittent Hypoxia to Enhance Motor Function After Spinal Cord Injury
NCT03071393
Validation of a Comprehensive Older Adult Screening Tool (COAST)
NCT03185585
Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus
NCT03103022
Evaluating MMPs in Burns
NCT03148977
Advance Directives Completion Rates and an Intervention to Address Health Literacy in a Clinic Population
NCT02702284
Combining tDCS and Neurorehabilitation to Treat Age-related Deficits of Mobility and Cognition: UPfront Walking Study
NCT03122236
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.